FRARA, STEFANO
 Distribuzione geografica
Continente #
AS - Asia 967
NA - Nord America 435
SA - Sud America 322
EU - Europa 174
Continente sconosciuto - Info sul continente non disponibili 84
AF - Africa 22
OC - Oceania 2
Totale 2.006
Nazione #
US - Stati Uniti d'America 389
BR - Brasile 245
SG - Singapore 223
VN - Vietnam 180
BD - Bangladesh 164
HK - Hong Kong 151
CN - Cina 138
IT - Italia 110
KR - Corea 49
AR - Argentina 39
ID - Indonesia 22
MX - Messico 22
FR - Francia 18
CA - Canada 17
EC - Ecuador 16
RU - Federazione Russa 10
DE - Germania 8
IN - India 8
PL - Polonia 7
CL - Cile 6
CO - Colombia 6
IQ - Iraq 6
PY - Paraguay 6
ZA - Sudafrica 6
CR - Costa Rica 4
GB - Regno Unito 4
TR - Turchia 4
EG - Egitto 3
NL - Olanda 3
VE - Venezuela 3
AL - Albania 2
AU - Australia 2
BN - Brunei Darussalam 2
DZ - Algeria 2
ET - Etiopia 2
GR - Grecia 2
GT - Guatemala 2
JO - Giordania 2
KE - Kenya 2
MA - Marocco 2
MY - Malesia 2
NP - Nepal 2
OM - Oman 2
PH - Filippine 2
SE - Svezia 2
TN - Tunisia 2
AM - Armenia 1
AT - Austria 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BF - Burkina Faso 1
BH - Bahrain 1
BO - Bolivia 1
CZ - Repubblica Ceca 1
IE - Irlanda 1
KG - Kirghizistan 1
KH - Cambogia 1
NO - Norvegia 1
PK - Pakistan 1
PT - Portogallo 1
SA - Arabia Saudita 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TZ - Tanzania 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 1.922
Città #
Hong Kong 151
Ho Chi Minh City 70
Ashburn 67
Seoul 49
Beijing 38
Singapore 38
Hanoi 37
New York 33
San Jose 26
Santa Clara 23
São Paulo 20
Mexico City 17
Hillsboro 15
Los Angeles 14
Da Nang 12
Rome 12
Milan 9
Toronto 9
Brasília 8
Dallas 8
Padua 8
Thái Bình 8
Rio de Janeiro 7
Warsaw 7
Buffalo 6
Curitiba 6
Guayaquil 6
Haiphong 6
Biên Hòa 5
Bologna 5
Campinas 5
Chicago 5
Porto Alegre 5
Quito 5
Turin 5
Fortaleza 4
Frankfurt am Main 4
Jakarta 4
Johannesburg 4
Limburg an der Lahn 4
Philadelphia 4
San José 4
Santiago 4
Surabaya 4
Washington 4
Asunción 3
Baghdad 3
Bari 3
Belo Horizonte 3
Cabo Frio 3
Cairo 3
Caxias do Sul 3
Florence 3
Itaquaquecetuba 3
Manaus 3
Naples 3
Orem 3
Queens 3
Reston 3
Salvador 3
Santo André 3
St Petersburg 3
Addis Ababa 2
Amman 2
Araçatuba 2
Athens 2
Bandar Seri Begawan 2
Bandung 2
Birmingham 2
Boardman 2
Boerne 2
Buenos Aires 2
Bình Dương 2
Canoas 2
Carapicuíba 2
Catania 2
Contagem 2
Denver 2
Dhaka 2
Feira de Santana 2
Florianópolis 2
Formosa 2
Franca 2
Guatemala City 2
Huế 2
Hải Dương 2
Istanbul 2
Kissimmee 2
Kuala Lumpur 2
Limeira 2
Mauá 2
Mendoza 2
Miami 2
Montgomery 2
Moscow 2
Nairobi 2
Nashville 2
Natal 2
Pasadena 2
Phoenix 2
Totale 912
Nome #
Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement 93
New onset of Graves' disease after controlled ovarian stimulation: A case report and brief literature review 69
CURRENT AND EMERGING ASPECTS OF DIABETES MELLITUS IN ACROMEGALY 67
High prevalence of morphometric vertebral fractures opportunistically detected on thoracic radiograms in patients with non-functioning pituitary adenoma 55
Cholecalciferol Use Is Associated With a Decreased Risk of Incident Morphometric Vertebral Fractures in Acromegaly 49
Correction: Vitamin D status and supplementation before and after Bariatric Surgery: Recommendations based on a systematic review and meta‑analysis 48
Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement 47
Vitamin D status and supplementation before and after Bariatric Surgery: Recommendations based on a systematic review and meta-analysis 43
Distinct Clinical Features of Post-COVID-19 Vaccination Early-onset Graves' Disease 43
Treatment of hypoparathyroidism 41
Standards of care for medical management of acromegaly in pituitary tumor centers of excellence (PTCOE) 39
Vertebral fractures at hospitalization predict impaired respiratory function during follow-up of COVID-19 survivors 38
COVID-19 and hypopituitarism 38
Adrenal schwannoma: why should endocrinologists be aware of this uncommon tumour? 37
Hypocalcemia in COVID-19: Prevalence, clinical significance and therapeutic implications 36
Consensus Statement on Vitamin D Status Assessment and Supplementation: Whys, Whens, and Hows 34
Novel approaches to bone comorbidity in Cushing's disease: an update 33
Effects of Pegvisomant and Pasireotide LAR on Vertebral Fractures in Acromegaly Resistant to First-generation SRLs 33
Pilot study to define criteria for Pituitary Tumors Centers of Excellence (PTCOE): results of an audit of leading international centers 32
Osteopathy in mild adrenal Cushing's syndrome and Cushing disease 31
Incidence of morphometric vertebral fractures in adult patients with growth hormone deficiency 31
Response to the Letter to the Editor from Min et al.: Low vitamin D levels are associated with Long COVID syndrome in COVID-19 survivors 30
Acromegalic osteopathy 30
Ultrasound and FibroScan® Controlled Attenuation Parameter in patients with MAFLD: head to head comparison in assessing liver steatosis 30
High Prevalence of Radiological Vertebral Fractures in Women on Thyroid-Stimulating Hormone-Suppressive Therapy for Thyroid Carcinoma 30
Clinical Pharmacology of Oral Octreotide Capsules for the Treatment of Acromegaly 29
The emerging osteo-metabolic phenotype of COVID-19: clinical and pathophysiological aspects 28
Pituitary tumor centers of excellence for Cushing's disease 28
Low vitamin D levels are associated with Long COVID syndrome in COVID-19 survivors 28
Malignancy risk in indeterminate thyroid nodules with Hürthle cells: role of autoimmune thyroiditis 27
The osteo-metabolic phenotype of COVID-19: an update 27
Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly 27
In search of an ideal drug for safer treatment of obesity: The false promise of pseudoephedrine 27
Vitamin D in the Covid-19 era: a review with recommendations from a G.I.O.S.E.G. expert panel 26
Modern approach to resistant acromegaly 26
Lack of vitamin D predicts impaired long-term immune response to COVID-19 vaccination 26
Hypocalcemia is a distinctive biochemical feature of hospitalized COVID-19 patients 26
Novel approach to bone comorbidity in resistant acromegaly 26
Correction: Results from ACROCOVID: an international survey on the care of acromegaly during the COVID-19 era 25
Hypocalcemia in COVID-19 is associated with low vitamin D levels and impaired compensatory PTH response 25
Pituitary Diseases and Bone 24
Results from ACROCOVID: an international survey on the care of acromegaly during the COVID-19 era 24
New tools for bone health assessment in secreting pituitary adenomas 23
An Italian survey of compliance with major guidelines for L-thyroxine of primary hypothyroidism 23
TSH-secreting pituitary adenomas and bone 23
Sarcopenic obesity research perspectives outlined by the sarcopenic obesity global leadership initiative (SOGLI) - Proceedings from the SOGLI consortium meeting in rome November 2022 22
Vitamin D Levels Are Associated with Blood Glucose and BMI in COVID-19 Patients, Predicting Disease Severity 21
High Prevalence of Vertebral Fractures Associated With Preoperative GH Levels in Patients With Recent Diagnosis of Acromegaly 21
Low vitamin D levels predict outcomes of COVID-19 in patients with both severe and non-severe disease at hospitalization 21
Diabetes in Cushing Disease 20
Pathophysiology and evaluation of bone health in adrenal diseases 20
Consensus on acromegaly therapeutic outcomes: an update 19
Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experience 18
New medical therapies of acromegaly 18
Correction to: Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly (Pituitary, 10.1007/s11102-018-0873-7) 15
Diabetes-Induced Osteoporosis: Dual Energy X-Ray Absorptiometry Bone Quality Is Better than Bone Quantity 15
The Hypothalamus 15
Acromegalic osteopathy: An update 14
A consensus on the diagnosis and treatment of acromegaly comorbidities: An update 14
Medical management pathways for Cushing's disease in pituitary tumors centers of excellence (PTCOEs) 13
Bone safety of dual-release hydrocortisone in patients with hypopituitarism 13
Body mass index predicts resistance to active vitamin D in patients with hypoparathyroidism 12
CURRENT AND FUTURE MEDICAL TREATMENTS FOR PATIENTS WITH ACROMEGALY 11
The GH-releasing effect of acylated ghrelin in normal subjects is refractory to GH acute auto-feedback but is inhibited after short-term GH administration inducing IGF1 increase 11
Vitamin D and Glucocorticoid-Induced Osteoporosis 11
MANAGEMENT OF ENDOCRINE DISEASE: Risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects 10
High prevalence of radiological vertebral fractures inpatients With TSH-secreting pituitary adenoma 9
Vertebral fractures may occur early in the history of Cushing disease associating with male gender and degree of cortisol secretion 9
Case Report: Bilateral lens dislocation as an atypical presentation of acromegaly and review of the ocular effects of GH/IGF-1 excess 8
Skeletal fragility: an emerging complication of Ehlers–Danlos syndrome 7
Pituitary Tumors Centers of Excellence 7
High-resolution-cone beam tomography analysis of bone microarchitecture in patients with acromegaly and radiological vertebral fractures 7
Primary hyperparathyroidism in prostate cancer: guilty or not guilty? 7
GH/IGF-I and bone 6
Gender differences in the glycometabolic and cardiovascular features of acromegaly 6
THE MODERN CRITERIA FOR MEDICAL MANAGEMENT OF ACROMEGALY 6
Somatostatin analogs in the treatment of neuroendocrine tumors: Current and emerging aspects 5
Vitamin D in Gut and Systemic Immune Tolerance and in Infections' Risk: An International Evidence-Based Consensus Statement 5
Consensus on acromegaly complications: an update 4
Romosozumab super-responders in clinical practice: insights from a large Italian multicenter cohort of women with severe postmenopausal osteoporosis 3
Subclinical thyrotoxicosis and bone 3
Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study 3
Metabolic syndrome in cushing's syndrome patients: Does gender matter? 2
Totale 2.006
Categoria #
all - tutte 12.326
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.326


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2025/20261.863 247 30 227 350 183 45 51 182 89 94 133 232
2026/2027143 37 80 26 0 0 0 0 0 0 0 0 0
Totale 2.006